Akèy › Alòpesi Areat › Ohio
Etid klinik pou Alòpesi Areat nan Ohio
6 etid pou Alòpesi Areat ap chèche patisipan nan sit nan Ohio.
Vil nan Ohio
Tèks ofisyèl etid la (Anglè)
A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
- Bexley Dermatology Research, Bexley
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 18, 2026 · NCT06873945A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
- Dermatologists of Southwestern Ohio (DSWO) /ID# 282818, Fairborn
Ap rekriteFaz 3
Laj 6 a 17 · Tout sèks · Mizajou Sep 17, 2026 · NCT07772492HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
- The Ohio State University Wexner Medical Center, Columbus
Ap rekriteFaz 1
Laj 18 a 70 · Tout sèks · Mizajou Sep 15, 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
- Bexley Dermatology Research, Bexley
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 10, 2026 · NCT07733765A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
- Cleveland Clinic - Cleveland /ID# 258113, Cleveland
- Dermatologists of Southwest Ohio, Inc /ID# 260116, Mason
Ap rekriteFaz 3
Laj 12 a 63 · Tout sèks · Mizajou Aug 3, 2026 · NCT06012240Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
- Dermatologists Of Southwest Ohio, Mason
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Jan 28, 2026 · NCT07133308Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.